Alignment Healthcare, Inc. (ALHC) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Alignment Healthcare, Inc. (ALHC) trades at $20.00 with AI Score 95/100 (Grade A+). Alignment Healthcare, Inc. is a tech-enabled Medicare Advantage company focused on providing customized healthcare to seniors in the United States. Market cap: $4.13B, Sector: Healthcare.
Price as of Jul 23, 2026 · Last analyzed: May 10, 2026ALHC stock analysis for 2026: Analysts have set a consensus price target of $26.75 for Alignment Healthcare, Inc., suggesting 33.8% upside from the current price of $20.00. The AI MoonshotScore is 95/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
ALHC: the 3 scored disciplines are evenly split. Dominant signal: Growth Durability strong.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Alignment Healthcare, Inc. (ALHC) Healthcare & Pipeline Overview
Alignment Healthcare, Inc. delivers consumer-centric healthcare solutions through its tech-enabled Medicare Advantage platform. Operating primarily in California, North Carolina, and Nevada, the company focuses on providing customized healthcare to seniors. With a profit margin of 0.5% and a gross margin of 12.4%, ALHC aims to improve healthcare outcomes and experiences for its members.
What Is the Investment Thesis for ALHC?
Alignment Healthcare presents a notable research candidate within the growing Medicare Advantage market. The company's tech-enabled platform and focus on customized care position it to capitalize on the increasing demand for senior-focused healthcare solutions. With a market capitalization of $4.13B and a beta of 1.19, ALHC offers exposure to a high-growth sector. Key catalysts include expansion into new geographic markets and continued innovation in care delivery models. However, investors should be aware of potential risks, including regulatory changes and competition from established players. The company's profit margin of 0.5% and gross margin of 12.4% indicate areas for improvement in operational efficiency and profitability.
Based on FMP financials and quantitative analysis
ALHC Key Highlights
- Market Cap of $4.13B reflects investor confidence in Alignment Healthcare's growth potential within the Medicare Advantage market.
- Gross Margin of 12.4% indicates the profitability of Alignment Healthcare's core services, with opportunities for improvement through operational efficiencies.
- Profit Margin of 0.5% highlights the need for enhanced cost management and revenue optimization strategies.
- Beta of 1.19 suggests that Alignment Healthcare's stock price is more volatile than the overall market, potentially offering higher returns but also greater risk.
- Presence in California, North Carolina, and Nevada provides a solid foundation for expansion into new geographic markets.
Who Are ALHC's Competitors?
ALHC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals, Inc. | $114.48 | -2.20% | $5.75B | — |
| NVST Envista Holdings Corp. | $26.43 | -1.86% | $5.00B | 86 |
| APGE Apogee Therapeutics, Inc. | $134.26 | +0.13% | $8.31B | 73 |
| OSCR Oscar Health, Inc. | $28.92 | -1.97% | $7.50B | 39 |
| PRVA Privia Health Group, Inc. | $24.97 | -1.58% | $3.15B | 89 |
| CLOV Clover Health Investments, Corp. | $4.55 | -2.57% | $2.36B | 36 |
| MOH Molina Healthcare, Inc. | $205.59 | -7.15% | $10.7B | 77 |
| CNC Centene Corporation | $63.72 | -3.29% | $31.5B | 73 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ALHC's Key Strengths?
- Tech-enabled platform for personalized care
- Strong presence in California, North Carolina, and Nevada
- Focus on member engagement and retention
- Experienced management team
What Are ALHC's Weaknesses?
- Relatively small market share compared to larger competitors
- Profit margin of 0.5% indicates need for improved cost management
- Limited geographic diversification
- Dependence on Medicare Advantage regulations
What Could Drive ALHC Stock Higher?
- Expansion into new geographic markets, driving membership growth and revenue.
- Continued enhancement of technology platform, improving care delivery and operational efficiency.
- Strategic partnerships and acquisitions, expanding service offerings and market reach.
- Focus on value-based care models, improving health outcomes and reducing costs.
What Are the Key Risks for ALHC?
- Rich valuation — a P/E of 158.8 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Regulatory changes in the Medicare Advantage market, affecting reimbursement rates and plan design.
- Intense competition from established players, limiting market share and pricing power.
- Rising healthcare costs, impacting profitability and affordability.
- Economic downturn affecting enrollment, reducing premium revenue.
What Are the Growth Opportunities for ALHC?
- Expansion into New Geographic Markets: Alignment Healthcare has the opportunity to expand its Medicare Advantage plans into new states, targeting regions with significant senior populations and favorable regulatory environments. This expansion could drive substantial growth in membership and revenue. The Medicare Advantage market is projected to continue growing, offering a large addressable market for Alignment Healthcare's expansion efforts. Timeline: Ongoing, with potential for significant expansion within the next 3-5 years.
- Enhancement of Technology Platform: Investing in and enhancing its technology platform can enable Alignment Healthcare to further personalize care, improve operational efficiency, and reduce costs. This includes leveraging data analytics, artificial intelligence, and telehealth capabilities to deliver more effective and convenient care to members. The market for healthcare technology is rapidly growing, offering opportunities for Alignment Healthcare to adopt innovative solutions. Timeline: Ongoing, with continuous improvements and new features being added to the platform.
- Strategic Partnerships and Acquisitions: Alignment Healthcare can pursue strategic partnerships and acquisitions to expand its service offerings, enter new markets, and gain access to new technologies. This could include partnering with physician groups, hospitals, and other healthcare providers to create integrated care networks. The healthcare industry is consolidating, creating opportunities for Alignment Healthcare to participate in strategic transactions. Timeline: Ongoing, with potential for targeted acquisitions and partnerships in the near term.
- Focus on Value-Based Care: Alignment Healthcare can further emphasize value-based care models, aligning incentives with providers to improve health outcomes and reduce costs. This includes implementing risk-sharing arrangements, bundled payments, and other innovative payment models. The shift towards value-based care is a major trend in the healthcare industry, driven by the need to improve quality and reduce costs. Timeline: Ongoing, with increasing adoption of value-based care models.
- Increased Member Engagement and Retention: By focusing on member engagement and retention, Alignment Healthcare can reduce churn and improve the lifetime value of its members. This includes providing personalized support, proactive outreach, and convenient access to care. High member satisfaction and retention are critical for long-term success in the Medicare Advantage market. Timeline: Ongoing, with continuous efforts to improve member experience and satisfaction.
What Opportunities Does ALHC Have?
- Expansion into new geographic markets
- Strategic partnerships and acquisitions
- Increased adoption of value-based care models
- Further enhancement of technology platform
What Threats Does ALHC Face?
- Intense competition from established players
- Regulatory changes in the Medicare Advantage market
- Rising healthcare costs
- Economic downturn affecting enrollment
What Are ALHC's Competitive Advantages?
- Technology-enabled platform for personalized care.
- Strong presence in key geographic markets.
- Focus on member engagement and retention.
- Expertise in Medicare Advantage regulations and compliance.
What Does ALHC Do?
Founded in 2013 and headquartered in Orange, California, Alignment Healthcare, Inc. is a tech-enabled Medicare Advantage company committed to transforming healthcare for seniors. The company operates a consumer-centric healthcare platform that delivers customized healthcare solutions to its members. Alignment Healthcare owns and operates Medicare Advantage plans in California, North Carolina, and Nevada, providing comprehensive coverage and coordinated care. Their offerings include professional, institutional, and ancillary services to members enrolled in their plans and certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. Alignment Healthcare distinguishes itself through its technology-driven approach, leveraging data analytics and innovative tools to enhance the member experience and improve health outcomes. The company's care model focuses on personalized care plans, proactive engagement, and seamless coordination of services. By integrating technology with a deep understanding of the senior population's needs, Alignment Healthcare aims to deliver superior healthcare value and improve the quality of life for its members. The company's commitment to innovation and member-centricity positions it as a key player in the evolving Medicare Advantage landscape.
What Products and Services Does ALHC Offer?
- Operates a tech-enabled Medicare Advantage platform.
- Provides customized healthcare to seniors in the United States.
- Offers Medicare Advantage plans in California, North Carolina, and Nevada.
- Coordinates and provides covered health care services.
- Delivers professional, institutional, and ancillary services to members.
- Focuses on consumer-centric healthcare solutions.
- Utilizes data analytics to improve health outcomes.
How Does ALHC Make Money?
- Generates revenue through premiums from Medicare Advantage plans.
- Manages healthcare costs through coordinated care and value-based arrangements.
- Leverages technology to improve efficiency and personalize care.
- Expands market reach through geographic expansion and strategic partnerships.
What Industry Does ALHC Operate In?
Alignment Healthcare operates within the rapidly expanding Medicare Advantage market, driven by the aging population and increasing demand for comprehensive healthcare solutions. The industry is characterized by intense competition among established players and new entrants, all vying for market share. Key trends include the adoption of technology-enabled care models, the shift towards value-based care, and the increasing focus on member experience. Alignment Healthcare's tech-enabled platform and focus on customized care position it to compete effectively in this dynamic landscape. Competitors like OSCR: Oscar Health, Inc. and PRVA: Privia Health Group, Inc. also operate in the healthcare space, focusing on technology and patient care.
Who Are ALHC's Key Customers?
- Seniors eligible for Medicare.
- Individuals seeking comprehensive healthcare coverage.
- Members enrolled in Medicare Advantage plans.
- Beneficiaries in California, North Carolina, and Nevada.
FY2026 estForward Outlook
Wall Street analysts project Alignment Healthcare, Inc. revenue of about $5.19B for fiscal 2026, with EPS near $0.19. The estimate reflects 9 contributing analysts.
F-Score 6/9Financial Health
Alignment Healthcare, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 5.27 places it in the safe zone, indicating low near-term bankruptcy risk.
ROE 11%Key Financial Metrics
Return on equity for Alignment Healthcare, Inc. stands at 11.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.6%, showing how much profit it generates from its asset base. ALHC trades at a trailing price-to-earnings ratio of 158.84, above the Healthcare sector average of ~23x. Its free cash flow yield is 7.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.75 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.6%, the inverse of the P/E and a quick read on earnings relative to price.
Alignment Healthcare, Inc. (ALHC) Valuation Context
Valued at $4.13B, ALHC is classified as a mid-cap stock. Relative to its peer group, ALHC's quantitative score of 95/100 is above the peer average of 72/100.
ALHC Revenue & Earnings Trend
In Q1 2026, ALHC generated $1.24B in top-line revenue, marking a sequential increase of 22.0%. The company recorded net income of $11.4M, with diluted EPS of $0.05. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this mid-cap Healthcare company. Across the four most recent quarters, ALHC averaged $0.02 in diluted EPS.
Company Profile
Alignment Healthcare, Inc. operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Orange, US. The company is led by CEO John E. Kao. ALHC has traded publicly since 2021.
ALHC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recientes compras de acciones por parte de ejecutivos sugieren confianza en el futuro de la empresa.
- La comunidad ha mostrado un aumento en la percepción positiva, impulsada por la expansión de servicios en nuevos mercados.
- Las iniciativas de innovación en atención médica están generando un interés creciente entre los inversores.
- Los comentarios de analistas destacan el potencial de crecimiento en un sector en constante evolución.
Bear Case
- El sentimiento de la comunidad ha sido cauteloso debido a la competencia creciente en el sector de salud.
- Preocupaciones sobre la sostenibilidad de los márgenes de beneficios en un entorno regulatorio cambiante.
- Algunos inversores expresan dudas sobre la capacidad de la empresa para escalar sus operaciones efectivamente.
- La volatilidad en el mercado de salud podría afectar la confianza de los inversores a corto plazo.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $1.24B | $11M | $0.05 |
| Q4 2025 | $1.01B | -$11M | -$0.05 |
| Q3 2025 | $994M | $4M | $0.02 |
| Q2 2025 | $1.02B | $16M | $0.07 |
Based on FMP financials and quantitative analysis
ALHC Latest News
-
1 of Wall Street’s Favorite Stocks to Own for Decades and 2 We Avoid
Yahoo! Finance: ALHC News · Jun 19, 2026
-
Alignment Healthcare Insider Sold Shares Worth $550,000, According to a Recent SEC Filing
MT Newswires · Jun 18, 2026
-
3 Reasons We Love Alignment Healthcare (ALHC)
Yahoo! Finance: ALHC News · Jun 17, 2026
-
2 Stocks Under $50 with Promising Prospects and 1 Facing Headwinds
Yahoo! Finance: ALHC News · Jun 17, 2026
ALHC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ALHC.
Price Targets
Consensus target: $26.75
ALHC MoonshotScore
What does this score mean?
The MoonshotScore rates ALHC 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Latest News
1 of Wall Street’s Favorite Stocks to Own for Decades and 2 We Avoid
Alignment Healthcare Insider Sold Shares Worth $550,000, According to a Recent SEC Filing
3 Reasons We Love Alignment Healthcare (ALHC)
2 Stocks Under $50 with Promising Prospects and 1 Facing Headwinds
Leadership: John E. Kao
CEO
John E. Kao serves as the CEO of Alignment Healthcare, bringing extensive experience in the healthcare industry. His career includes leadership roles at various healthcare organizations, where he focused on driving innovation and improving patient outcomes. Kao's background encompasses strategic planning, operational management, and business development. He is known for his expertise in navigating the complexities of the healthcare landscape and fostering a culture of innovation and collaboration.
Track Record: Under John E. Kao's leadership, Alignment Healthcare has expanded its market presence and enhanced its technology platform. He has overseen the company's growth in key geographic markets and the implementation of innovative care delivery models. Kao's strategic decisions have contributed to Alignment Healthcare's position as a leading tech-enabled Medicare Advantage company. He manages 1679 employees.
Common Questions About ALHC (Healthcare)
What does the AI Score mean for ALHC?
ALHC holds an AI Score of 95/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. Alignment Healthcare, Inc. is a tech-enabled Medicare Advantage company focused on providing customized healthcare to seniors in the United States. They operate Medicare Advantage plans …
What does Alignment Healthcare, Inc. do?
Alignment Healthcare, Inc. operates as a tech-enabled Medicare Advantage company, providing customized healthcare solutions to seniors in the United States. The company owns and operates Medicare Advantage plans in California, North Carolina, and Nevada. Alignment Healthcare focuses on delivering consumer-centric healthcare through its technology platform, offering coordinated care and personalized support to its members. The company's goal is to improve health outcomes and enhance the overall healthcare experience for seniors.
What do analysts say about ALHC stock?
Analyst coverage of Alignment Healthcare, Inc. (ALHC) generally focuses on its growth potential within the expanding Medicare Advantage market. Key valuation metrics include price-to-earnings ratio, price-to-sales ratio, and enterprise value-to-EBITDA. Analysts consider factors such as membership growth, geographic expansion, and technology innovation when assessing ALHC's prospects.
What are the main risks for ALHC?
Alignment Healthcare faces several key risks, including regulatory changes in the Medicare Advantage market, which could impact reimbursement rates and plan design. Intense competition from larger, established players poses a threat to market share and pricing power. Rising healthcare costs could squeeze profit margins and affect affordability for members.
How does Alignment Healthcare differentiate itself from other Medicare Advantage providers?
Alignment Healthcare differentiates itself through its tech-enabled platform and focus on customized care. The company leverages data analytics and innovative technologies to personalize care plans and improve health outcomes. Alignment Healthcare also emphasizes member engagement and proactive outreach, providing personalized support and convenient access to care.
What are the key growth opportunities for ALHC in healthcare?
Alignment Healthcare has several key growth opportunities within the healthcare sector. These include expanding into new geographic markets, enhancing its technology platform, pursuing strategic partnerships and acquisitions, focusing on value-based care models, and increasing member engagement and retention. By capitalizing on these opportunities, Alignment Healthcare can drive sustainable growth and strengthen its position as a leading tech-enabled Medicare Advantage company.
What are the key factors to evaluate for ALHC?
Alignment Healthcare, Inc. (ALHC) holds an AI score of 95/100 (high). P/E: 158.8x vs the S&P 500's ~20-25x. Analysts target $26.75 (+34%). Not financial advice.
How frequently does ALHC data refresh on this page?
ALHC's price was last updated on Jul 23, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven ALHC's recent stock price performance?
Alignment Healthcare, Inc. (ALHC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Tech-enabled platform for personalized care. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial metrics are as of the latest available reporting period.